Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric cancer in real-world patients: Updated analysis.

被引：0
|
作者：
Shimozaki, Keitaro
Fukuda, Koshiro
Ooki, Akira
Nakayama, Izuma
Yoshino, Koichiro
Udagawa, Shohei
Fukuoka, Shota
Osumi, Hiroki
Ogura, Mariko
Wakatsuki, Takeru
Takahari, Daisuke
Shinozaki, Eiji
Chin, Keisho
Yamaguchi, Kensei
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Koto Ku, Koto, Japan
[2] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Gastroenterol Chemotherapy, Tokyo, Japan
[3] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[4] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Advanved Med Dev, Tokyo, Japan
[5] Canc Inst Hosp, Japanese Fdn Canc Res, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.341
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：341 / 341
页数：1
相关论文
共 50 条
  • [31] Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer
    Urakci, Zuhat
    Ebinc, Senar
    Tunc, Sezai
    Kalkan, Ziya
    Oruc, Zeynep
    Kucukoner, Mehmet
    Kaplan, Muhammet Ali
    Isikdogan, Abdurrahman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [32] Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study
    Xu, Qian
    Yi, Dan
    Jia, Caiyan
    Kong, Fanming
    Jia, Yingjie
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Impact of adding nivolumab to first-line chemotherapy in patients with advanced gastric cancer.
    Utsumi, Mai
    Yukami, Hiroki
    Okemoto, Dai
    Kadono, Toru
    Yamaguchi, Toshifumi
    Goto, Masahiro
    Nishikawa, Hiroki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 334 - 334
  • [34] Authors' reply to 'RE: A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group'
    Nishina, Tomohiro
    Boku, Narikazu
    Kurokawa, Yukinori
    Sasaki, Keita
    Machida, Ryunosuke
    Yoshikawa, Takaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 55 (01) : 89 - 90
  • [35] Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study
    Lingyun Zhang
    Jiayu Zhang
    Yan Wang
    Wei Li
    Shan Yu
    Qian Li
    Yiyi Yu
    Tianshu Liu
    Yuehong Cui
    BMC Gastroenterology, 22
  • [36] Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study
    Zhang, Lingyun
    Zhang, Jiayu
    Wang, Yan
    Li, Wei
    Yu, Shan
    Li, Qian
    Yu, Yiyi
    Liu, Tianshu
    Cui, Yuehong
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [37] Efficacy of a triplet and doublet-based chemotherapy as first-line therapy in patients with HER2-negative metastatic gastric cancer: a retrospective analysis from the clinical practice
    Laterza, Maria Maddalena
    Pompella, Luca
    Petrillo, Angelica
    Tirino, Giuseppe
    Pappalardo, Annalisa
    Orditura, Michele
    Troiani, Teresa
    Ciardiello, Fortunato
    Di Martino, Natale
    De Vita, Ferdinando
    MEDICAL ONCOLOGY, 2017, 34 (11)
  • [38] First-line ribociclib plus endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled efficacy analysis
    Tripathy, D.
    Hortobagyi, G.
    Chan, A.
    Im, S-A
    Chia, S.
    Yardley, D.
    Esteva, F. J.
    Hurvitz, S.
    Kong, O.
    Bao, W.
    Lorenc, K. Rodriguez
    Diaz-Padilla, I.
    Slamon, D. J.
    CANCER RESEARCH, 2019, 79 (04)
  • [39] Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study
    Bi, Pingping
    Wang, Xi
    Liu, Rui
    Li, Xiuqin
    Wei, Shanrong
    Zhao, Jiawen
    Tan, Xin
    Zhang, Fan
    Mao, Qing
    Zhang, Ying
    Tang, Baoyan
    Xun, Xueqiong
    Guo, Rong
    Zheng, Kai
    Zhou, Shaoqiang
    Tang, Shicong
    SURGERY OPEN SCIENCE, 2023, 16 : 171 - 183
  • [40] Efficacy of a triplet and doublet-based chemotherapy as first-line therapy in patients with HER2-negative metastatic gastric cancer: a retrospective analysis from the clinical practice
    Maria Maddalena Laterza
    Luca Pompella
    Angelica Petrillo
    Giuseppe Tirino
    Annalisa Pappalardo
    Michele Orditura
    Teresa Troiani
    Fortunato Ciardiello
    Natale Di Martino
    Ferdinando De Vita
    Medical Oncology, 2017, 34
12345